Epidauros offers a variety of add-on services to complement its solutions from sample collection to clinically-relevant output. These add-on-services include:

 

In particular, Epidauros provides a value-added consulting service not only as part of its regular solution offering, but also related to specific projects, e.g.

• Clinical trial-related support
• Scientific & regulatory-related support

 

As an example, Epidauros provided scientific consulting for one of its customers regarding a candidate gene approach in a CNS disorder.

 

Our support work is normally summarized in a detailed report which is geared towards facilitating important decision-making about the further development of clinical compounds.

 

Epidauros also facilitates pharmacogenetic-related workshops based on specific customer requests. Such workshops can be held both internally and externally and can form part of investigator meetings.

 

Training topics could include:

• basic pharmacogenetic science
• application of pharmacogenetics in clinical routine
• pharmacogenetics in support of clinical trials

 

Epidauros provides GLP-compliant sample storage solutions for

• archival
• maintenance
• retrieval
• aliquoting
• redistribution

of client blood, DNA or other tissue samples meeting the legal ethical requirements. Samples can be stored at –20ºC or –80ºC in the following sample coding categories: anonymous, identifiable, or identified. Customised sample collection kits can be provided as well. These samples can serve as basis material for continued or future studies.

 

Over the years, Epidauros has made important contributions to the basic understanding of pharmacogenetics, especially in the area of drug transporter-related polymorphisms. Our experienced team of scientists and bioinformaticians are well versed in the processing of pharmacogenetic questions of any type and complexity.
Thus we offer to our client-base tailor-made solutions – ranging from client-specific assay development right up to specific pharmacogenetic research projects (e.g. discovery and characterization of novel biomarkers) – to ensure optimal support for their respective drug development programmes. We also assist our clients in developing safer and more effective drugs by identifying genetic variations (mutations and polymorphisms) and their association with interindividual differences in drug efficacy and tolerance.